Related Experiment Video
Updated: Jul 26, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Outcomes After Endovascular Aortic Intervention in Patients With Connective Tissue Disease
Karl Wilhelm Olsson1, Kevin Mani1, Anne Burdess1
1Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Insights
Endovascular aortic repair in connective tissue diseases (CTDs) shows high success and acceptable midterm survival, challenging previous recommendations. Further research may support its inclusion in guidelines.
Area of Science:
- Cardiovascular Surgery
- Genetics
- Vascular Medicine
Background:
- Endovascular aortic repair (EVAR) is generally not recommended for connective tissue diseases (CTDs) except in specific circumstances.
- Advancements in endovascular technology may warrant a reevaluation of this recommendation.
Purpose of the Study:
- To evaluate the midterm outcomes of EVAR in patients diagnosed with CTDs.
- To assess survival rates, secondary procedure rates, and conversion to open repair after EVAR in this population.
Main Methods:
- A descriptive retrospective study involving 171 patients with CTDs (Marfan, Loeys-Dietz, vEDS) from 18 aortic centers.
- Data collected on demographics, interventions, and short-term/midterm outcomes (2005-2020), analyzed December 2021-November 2022.
Main Results:
- High primary technical success (98.2%) and low 30-day mortality (2.9%).
- Midterm survival rates were comparable to open repair, varying by CTD type (e.g., 80.6% at 5 years for Marfan syndrome).
- High rate of secondary procedures (53.2%), but low conversion to open repair (8.2%).
Conclusions:
- EVAR in CTD patients demonstrates high early technical success and low perioperative mortality.
- Midterm survival is comparable to open surgery, suggesting EVAR is a viable option.
- Potential for EVAR to be included in future treatment guidelines for CTDs due to technological advancements and favorable outcomes.
Importance:
Endovascular treatment is not recommended for aortic pathologies in patients with connective tissue diseases (CTDs) other than in redo operations and as bridging procedures in emergencies. However, recent developments in endovascular technology may challenge this dogma.
Objective:
To assess the midterm outcomes of endovascular aortic repair in patients with CTD.
Design, Setting, And Participants:
For this descriptive retrospective study, data on demographics, interventions, and short-term and midterm outcomes were collected from 18 aortic centers in Europe, Asia, North America, and New Zealand. Patients with CTD who had undergone endovascular aortic repair from 2005 to 2020 were included. Data were analyzed from December 2021 to November 2022.
Exposure:
All principal endovascular aortic repairs, including redo surgery and complex repairs of the aortic arch and visceral aorta.
Main Outcomes And Measures:
Short-term and midterm survival, rates of secondary procedures, and conversion to open repair.
Results:
In total, 171 patients were included: 142 with Marfan syndrome, 17 with Loeys-Dietz syndrome, and 12 with vascular Ehlers-Danlos syndrome (vEDS). Median (IQR) age was 49.9 years (37.9-59.0), and 107 patients (62.6%) were male. One hundred fifty-two (88.9%) were treated for aortic dissections and 19 (11.1%) for degenerative aneurysms. One hundred thirty-six patients (79.5%) had undergone open aortic surgery before the index endovascular repair. In 74 patients (43.3%), arch and/or visceral branches were included in the repair. Primary technical success was achieved in 168 patients (98.2%), and 30-day mortality was 2.9% (5 patients). Survival at 1 and 5 years was 96.2% and 80.6% for Marfan syndrome, 93.8% and 85.2% for Loeys-Dietz syndrome, and 75.0% and 43.8% for vEDS, respectively. After a median (IQR) follow-up of 4.7 years (1.9-9.2), 91 patients (53.2%) had undergone secondary procedures, of which 14 (8.2%) were open conversions.
Conclusions And Relevance:
This study found that endovascular aortic interventions, including redo procedures and complex repairs of the aortic arch and visceral aorta, in patients with CTD had a high rate of early technical success, low perioperative mortality, and a midterm survival rate comparable with reports of open aortic surgery in patients with CTD. The rate of secondary procedures was high, but few patients required conversion to open repair. Improvements in devices and techniques, as well as ongoing follow-up, may result in endovascular treatment for patients with CTD being included in guideline recommendations.
Related Concept Videos
Aneurysm III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Peripheral Artery Disease V: Postoperative Nursing Management
Aortic Regurgitation III: Medical Management
Aneurysm IV: Nursing Management

